iBio (IBIO) Net Margin (QoQ) (2011 - 2025)
iBio (IBIO) Net Margin (QoQ) (2011 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - |
| 10 | iBio | 178.20 Mn | 178.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -325,100.00 |
| Sep 30, 2021 | -626,515.00 |
| Jun 30, 2021 | 102,019.00 |
| Mar 31, 2021 | 15,247.00 |
| Dec 31, 2020 | 69,115.00 |
| Sep 30, 2020 | -153,172.00 |
| Jun 30, 2020 | 461,685.00 |
| Mar 31, 2020 | 314,649.00 |
| Dec 31, 2019 | -389,151.00 |
| Sep 30, 2019 | -361,893.00 |
| Jun 30, 2019 | 23,888.00 |
| Mar 31, 2019 | -11,701.00 |
| Dec 31, 2018 | 922,353.00 |
| Sep 30, 2018 | -499,363.00 |
| Jun 30, 2018 | 23,516.00 |
| Mar 31, 2018 | -257,069.00 |
| Dec 31, 2017 | 59,931.00 |
| Sep 30, 2017 | -20,173.00 |
| Jun 30, 2017 | 765,751.00 |
| Mar 31, 2017 | -634,061.00 |